Photo of Ahmad Tarhini from moffitt.org
May 31, 2024, 22:07
Ahmad Tarhini: Employing a machine learning framework to molecular data from patients with melanoma
Ahmad Tarhini, Director of Cutaneous Clinical and Translational Research at Moffitt Cancer Center, shared on LinkedIn:
“In this abstract, we employ a machine learning framework to molecular data from patients with melanoma in order to study immune cell states and multicellular ecosystems in an effort to refine the process of patient selection for immunotherapy and gain insights into immune resistance mechanisms that guide future immuno-oncology drug development with Xuefeng Wang.”
Proceed to the abstract.
Source: Ahmad Tarhini/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14